Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -7.13.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 5 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-39.00
EARNINGS PER SHARE (EPS) AVG 3Y
-20.98
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
DataMEDS AI, Inc.
Market Cap
$8.23M
Earnings Per Share (EPS)
N/A
TTM Avg
-39.00
3Y Avg
-20.98
5Y Avg
N/A
Market Cap
$8.14M
Earnings Per Share (EPS)
-1.08
TTM Avg
-2.14
3Y Avg
-342.00
5Y Avg
-242.25
Market Cap
$8.03M
Earnings Per Share (EPS)
N/A
TTM Avg
-6.41
3Y Avg
-27.87
5Y Avg
-55.81
Market Cap
$7.95M
Earnings Per Share (EPS)
-6.39
TTM Avg
-9.59
3Y Avg
-7.41
5Y Avg
-7.93
Market Cap
$7.93M
Earnings Per Share (EPS)
-104.00
TTM Avg
-164.88
3Y Avg
-121.81
5Y Avg
-116.67
Market Cap
$8.53M
Earnings Per Share (EPS)
-65.58
TTM Avg
-8524.08
3Y Avg
-26524.29
5Y Avg
-21051.80
Market Cap
$7.76M
Earnings Per Share (EPS)
-68.91
TTM Avg
-299.00
3Y Avg
-268.50
5Y Avg
-367.67
Market Cap
$9.10M
Earnings Per Share (EPS)
-3.91
TTM Avg
-36.08
3Y Avg
-152.15
5Y Avg
-116.13
Market Cap
$7.34M
Earnings Per Share (EPS)
-23.59
TTM Avg
-251.09
3Y Avg
-121778.80
5Y Avg
-249058.36
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.23M | N/A | -39.00 | -20.98 | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | -1.08 | -2.14 | -342.00 | -242.25 |
| HeartSciences Inc. (HSCS)vs › | $8.03M | N/A | -6.41 | -27.87 | -55.81 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | -6.39 | -9.59 | -7.41 | -7.93 |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | -104.00 | -164.88 | -121.81 | -116.67 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -65.58 | -8524.08 | -26524.29 | -21051.80 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.76M | -68.91 | -299.00 | -268.50 | -367.67 |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.10M | -3.91 | -36.08 | -152.15 | -116.13 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | -23.59 | -251.09 | -121778.80 | -249058.36 |
| Longeveron Inc. (LGVN)vs › | $7.27M | -10.10 | -11.80 | -53.95 | -54.65 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -71.50 |
| 2024-12-31 | -6.50 |
| 2023-12-31 | -3.00 |
| 2022-12-31 | -2.90 |
